The Use of Organoclays as Excipient for Metformin Delivery: Experimental and Computational Study.
Metformin
/ chemistry
Clay
/ chemistry
Adsorption
Drug Carriers
/ chemistry
Excipients
/ chemistry
X-Ray Diffraction
Aluminum Silicates
/ chemistry
Drug Delivery Systems
Spectroscopy, Fourier Transform Infrared
Silicates
/ chemistry
Models, Molecular
Bentonite
/ chemistry
Calorimetry, Differential Scanning
Drug Liberation
adsorption
clay minerals
drug release
metformin
molecular modeling
smectite
Journal
Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009
Informations de publication
Date de publication:
28 Sep 2024
28 Sep 2024
Historique:
received:
13
08
2024
revised:
18
09
2024
accepted:
26
09
2024
medline:
16
10
2024
pubmed:
16
10
2024
entrez:
16
10
2024
Statut:
epublish
Résumé
This work combines experimental and computational modeling studies for the preparation of a composite of metformin and an organoclay, examining the advantages of a Tunisian clay used for drug delivery applications. The clay mineral studied is a montmorillonite-like smectite (Sm-Na), and the organoclay derivative (HDTMA-Sm) was used as a drug carrier for metformin hydrochloride (MET). In order to assess the MET loading into the clays, these materials were characterized by means of cation exchange capacity assessment, specific surface area measurement, and with the techniques of X-ray diffraction (XRD), differential scanning calorimetry, X-ray fluorescence spectroscopy, and Fourier-transformed infrared spectroscopy. Computational molecular modeling studies showed the surface adsorption process, identifying the clay-drug interactions through hydrogen bonds, and assessing electrostatic interactions for the hybrid MET/Sm-Na and hydrophobic interactions and cation exchange for the hybrid MET/HDTMA-Sm. The results show that the clays (Sm-Na and HDTMA-Sm) are capable of adsorbing MET, reaching a maximum load of 12.42 and 21.97 %, respectively. The adsorption isotherms were fitted by the Freundlich model, indicating heterogeneous adsorption of the studied adsorbate-adsorbent system, and they followed pseudo-second-order kinetics. The calculations of ΔGº indicate the spontaneous and reversible nature of the adsorption. The calculation of ΔH° indicates physical adsorption for the purified clay (Sm-Na) and chemical adsorption for the modified clay (HDTMA-Sm). The release of intercalated MET was studied in media simulating gastric and intestinal fluids, revealing that the purified clay (Sm-Na) and the modified organoclay (HDTMA-Sm) can be used as carriers in controlled drug delivery in future clinical applications. The molecular modeling studies confirmed the experimental phenomena, showing that the main adsorption mechanism is the cation exchange process between proton and MET cations into the interlayer space.
Identifiants
pubmed: 39407542
pii: molecules29194612
doi: 10.3390/molecules29194612
pii:
doi:
Substances chimiques
Metformin
9100L32L2N
Clay
T1FAD4SS2M
Drug Carriers
0
Excipients
0
Aluminum Silicates
0
Silicates
0
Smectite
A3N5ZCN45C
Bentonite
1302-78-9
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Ministerio de Ciencia, Innovación y Universidades
ID : PID2022-137603OB-I00
Organisme : Consejería de Economía, Conocimiento, Empresas y Universidad
ID : P18-RT-3786